Kim Hyeun Bum, Singer Randall S, Borewicz Klaudyna, White Bryan A, Sreevatsan Srinand, Johnson Timothy J, Espejo Luis A, Isaacson Richard E
Department of Veterinary and Biomedical Science, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.
Am J Vet Res. 2014 May;75(5):460-7. doi: 10.2460/ajvr.75.5.460.
To evaluate the effects of tylosin on C-reactive protein concentration, carriage of Salmonella enterica, and antimicrobial resistance genes in commercial pigs.
120 pigs on 2 commercial farms.
A cohort of sixty 10-week-old pigs in 4 pens/farm (15 pigs/pen) was randomly selected. Equal numbers of pigs were given feed containing tylosin (40 μg/g of feed) for 0, 6, or 12 weeks. C-reactive protein concentrations were measured, microbial culture for S enterica in feces was performed, and antimicrobial resistance genes in feces were quantified.
No significant associations were detected between C-reactive protein concentration or S enterica status and tylosin treatment. During the 12 weeks of tylosin administration, increased levels of 6 antimicrobial resistance genes did not occur.
Treatment of pigs with tylosin did not affect C-reactive protein concentration or reduce carriage or load of S enterica. There was no evidence that pigs receiving tylosin had increased carriage of the 6 antimicrobial resistance genes measured.
S enterica is a public health concern. Use of the antimicrobial growth promoter tylosin did not pose a public health risk by means of increased carriage of S enterica.
评估泰乐菌素对商品猪C反应蛋白浓度、肠炎沙门氏菌携带情况及抗菌药物耐药基因的影响。
两个商业农场的120头猪。
从每个农场的4个猪栏中随机选取一组共60头10周龄猪(每个猪栏15头)。给数量相等的猪分别饲喂含泰乐菌素(40μg/g饲料)的饲料0周、6周或12周。检测C反应蛋白浓度,对粪便进行肠炎沙门氏菌微生物培养,并对粪便中的抗菌药物耐药基因进行定量分析。
未检测到C反应蛋白浓度或肠炎沙门氏菌状态与泰乐菌素治疗之间存在显著关联。在给予泰乐菌素的12周期间,6种抗菌药物耐药基因的水平未升高。
用泰乐菌素治疗猪不影响C反应蛋白浓度,也不会减少肠炎沙门氏菌的携带或负荷。没有证据表明接受泰乐菌素治疗的猪所检测的6种抗菌药物耐药基因的携带情况增加。
肠炎沙门氏菌是一个公共卫生问题。使用抗菌生长促进剂泰乐菌素不会因增加肠炎沙门氏菌的携带而构成公共卫生风险。